TREA

88167507 - TANNQUILYNNE

Follow

Information

  • Trademark
  • 88167507
  • Serial Number
    88167507
  • Registration Number
    6351061
  • Filing Date
    October 24, 2018
    6 years ago
  • Registration Date
    May 18, 2021
    3 years ago
  • Transaction Date
    May 18, 2021
    3 years ago
  • Status Date
    May 18, 2021
    3 years ago
  • Published for Opposition Date
    March 02, 2021
    3 years ago
  • Location Date
    May 18, 2021
    3 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    VAGHANI, MAYUR C
  • Attorney Docket Number
    6174-0134US1
    Attorney Name
    Michael T. Smith
    Law Office Assigned Location Code
    N60
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
TANNQUILYNNE
Case File Statements
  • GS0051: Syrups for pharmaceutical purposes for the treatment of Hyperglycemia, diabetes, prediabetes, insulin resistance, diabetic ketoacidosis (DKA), hyperglycemic hyperosmolar nonketotic syndrome (HHNS), Hyperthyroidism, Polyphagia, polydipsia, polyuria, glycosuria, increased thirst and a frequent need to Urinate, coma, abdominal pain, poor wound healing, Stomach and intestinal problems such as chronic constipation or diarrhea, Worse vision, Damage to eyes, blood vessels, or kidneys, hyperlipidemia, hypertriglyceridemia, hypercholesterolemia, obesity, hypertension, heart disease, heart attack, stroke, thrombosis, fatty liver, liver cirrhosis, hyperuricemia, gout, pain in joints, joint stiffness, redness and swelling, Autism, Asperger's disorder, panic disorder, post-traumatic stress disorder, pain, childhood learning disorder, attention deficit hyperactivity disorder (ADHD), Tourette's syndrome, mania, obsessive compulsive disorder, and other diseases or symptoms related to CNS disorder, metabolic disorder, or diabetes; Pharmaceutical preparations for the treatment of Hyperglycemia, diabetes, prediabetes, insulin resistance, diabetic ketoacidosis (DKA), hyperglycemic hyperosmolar nonketotic syndrome (HHNS), Hyperthyroidism, Polyphagia, polydipsia, polyuria, glycosuria, increased thirst and a frequent need to Urinate, coma, abdominal pain, poor wound healing, Stomach and intestinal problems such as chronic constipation or diarrhea, Worse vision, Damage to eyes, blood vessels, or kidneys, hyperlipidemia, hypertriglyceridemia, hypercholesterolemia, obesity, hypertension, heart disease, heart attack, stroke, thrombosis, fatty liver, liver cirrhosis, hyperuricemia, gout, pain in joints, joint stiffness, redness and swelling, Autism, Asperger's disorder, panic disorder, post-traumatic stress disorder, pain, childhood learning disorder, attention deficit hyperactivity disorder (ADHD), Tourette's syndrome, mania, obsessive compulsive disorder, and other diseases or symptoms related to CNS disorder, metabolic disorder, or diabetes; Pharmaceutical preparations for the treatment and prevention of Hyperglycemia, diabetes, prediabetes, insulin resistance, diabetic ketoacidosis (DKA), hyperglycemic hyperosmolar nonketotic syndrome (HHNS), Hyperthyroidism, Polyphagia, polydipsia, polyuria, glycosuria, increased thirst and a frequent need to Urinate, coma, abdominal pain, poor wound healing, Stomach and intestinal problems such as chronic constipation or diarrhea, Worse vision, Damage to eyes, blood vessels, or kidneys, hyperlipidemia, hypertriglyceridemia, hypercholesterolemia, obesity, hypertension, heart disease, heart attack, stroke, thrombosis, fatty liver, liver cirrhosis, hyperuricemia, gout, pain in joints, joint stiffness, redness and swelling, Autism, Asperger's disorder, panic disorder, post-traumatic stress disorder, pain, childhood learning disorder, attention deficit hyperactivity disorder (ADHD), Tourette's syndrome, mania, obsessive compulsive disorder, and other diseases or symptoms related to CNS disorder, metabolic disorder, or diabetes; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Transdermal patches for use in the treatment of Hyperglycemia, diabetes, prediabetes, insulin resistance, diabetic ketoacidosis (DKA), hyperglycemic hyperosmolar nonketotic syndrome (HHNS), Hyperthyroidism, Polyphagia, polydipsia, polyuria, glycosuria, increased thirst and a frequent need to Urinate, coma, abdominal pain, poor wound healing, Stomach and intestinal problems such as chronic constipation or diarrhea, Worse vision, Damage to eyes, blood vessels, or kidneys, hyperlipidemia, hypertriglyceridemia, hypercholesterolemia, obesity, hypertension, heart disease, heart attack, stroke, thrombosis, fatty liver, liver cirrhosis, hyperuricemia, gout, pain in joints, joint stiffness, redness and swelling, Autism, Asperger's disorder, panic disorder, post-traumatic stress disorder, pain, childhood learning disorder, attention deficit hyperactivity disorder (ADHD), Tourette's syndrome, mania, obsessive compulsive disorder, and other diseases or symptoms related to CNS disorder, metabolic disorder, or diabetes; Natural dietary supplements for the treatment of Hyperglycemia, diabetes, prediabetes, insulin resistance, diabetic ketoacidosis (DKA), hyperglycemic hyperosmolar nonketotic syndrome (HHNS), Hyperthyroidism, Polyphagia, polydipsia, polyuria, glycosuria, increased thirst and a frequent need to Urinate, coma, abdominal pain, poor wound healing, Stomach and intestinal problems such as chronic constipation or diarrhea, Worse vision, Damage to eyes, blood vessels, or kidneys, hyperlipidemia, hypertriglyceridemia, hypercholesterolemia, obesity, hypertension, heart disease, heart attack, stroke, thrombosis, fatty liver, liver cirrhosis, hyperuricemia, gout, pain in joints, joint stiffness, redness and swelling, Autism, Asperger's disorder, panic disorder, post-traumatic stress disorder, pain, childhood learning disorder, attention deficit hyperactivity disorder (ADHD), Tourette's syndrome, mania, obsessive compulsive disorder, and other diseases or symptoms related to CNS disorder, metabolic disorder, or diabetes
Case File Event Statements
  • 5/18/2021 - 3 years ago
    37 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 3/2/2021 - 3 years ago
    36 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 3/2/2021 - 3 years ago
    35 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 2/10/2021 - 3 years ago
    34 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 12/31/2020 - 4 years ago
    33 - CASE RETURNED TO EXAMINATION Type: OTHE
  • 12/31/2020 - 4 years ago
    32 - NOTICE OF ALLOWANCE CANCELLED Type: IUCN
  • 10/29/2020 - 4 years ago
    31 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 10/28/2020 - 4 years ago
    30 - ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED Type: ATRQ
  • 10/28/2020 - 4 years ago
    29 - PETITION TO DIRECTOR - CHANGE BASIS - GRANTED Type: PCBG
  • 10/28/2020 - 4 years ago
    28 - EXTENSION 3 GRANTED Type: EX3G
  • 9/10/2020 - 4 years ago
    27 - EXTENSION 3 FILED Type: EXT3
  • 10/18/2020 - 4 years ago
    26 - ASSIGNED TO PETITION STAFF Type: APET
  • 9/18/2020 - 4 years ago
    25 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 9/10/2020 - 4 years ago
    24 - TEAS EXTENSION RECEIVED Type: EEXT
  • 9/10/2020 - 4 years ago
    23 - TEAS PETITION TO AMEND BASIS RECEIVED Type: TPAD
  • 7/24/2020 - 4 years ago
    22 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 7/24/2020 - 4 years ago
    21 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 7/24/2020 - 4 years ago
    20 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR
  • 7/24/2020 - 4 years ago
    19 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 7/24/2020 - 4 years ago
    18 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 7/24/2020 - 4 years ago
    17 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 2/29/2020 - 4 years ago
    16 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 2/27/2020 - 4 years ago
    15 - EXTENSION 2 GRANTED Type: EX2G
  • 2/27/2020 - 4 years ago
    14 - EXTENSION 2 FILED Type: EXT2
  • 2/27/2020 - 4 years ago
    13 - TEAS EXTENSION RECEIVED Type: EEXT
  • 8/15/2019 - 5 years ago
    12 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 8/13/2019 - 5 years ago
    11 - EXTENSION 1 GRANTED Type: EX1G
  • 8/13/2019 - 5 years ago
    10 - EXTENSION 1 FILED Type: EXT1
  • 8/13/2019 - 5 years ago
    9 - TEAS EXTENSION RECEIVED Type: EEXT
  • 3/12/2019 - 5 years ago
    8 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 1/15/2019 - 5 years ago
    7 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 1/15/2019 - 5 years ago
    6 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 12/26/2018 - 6 years ago
    5 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 12/7/2018 - 6 years ago
    4 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 12/7/2018 - 6 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 11/6/2018 - 6 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 10/27/2018 - 6 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP